PMVP

PMV Pharmaceuticals, Inc.

Latest Form 4:Sale$1.5MbyORBIMED ADVISORS LLC (10% Owner) · filed Oct 27, 2025

PMV Pharmaceuticals, Inc. (PMVP) has 3 SEC Form 4 filings (3 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Oct 29, 2025.

Insiders have net sold $2.4M over the trailing 6 months.

  • Industry:Biotechnology
  • CEO:David H. Mack
  • Employees:54
  • HQ:Princeton, NJ, US
  • IPO:2020-09-25

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$2.4M

reported sales (SEC code S)

Unique Insiders

1

in the rolling window

Source
Sale$1.5MOct 27SEC ↗
Sale$900KSep 12SEC ↗

Related companies

PMV Pharmaceuticals, Inc. is in the Healthcare sector.